What to Prepare Before Your First OEM/ODM Conversation with a Korean Manufacturer

GlowBridge
Apr 3
3 min read

Entering the Korean beauty manufacturing ecosystem can be a significant competitive advantage for U.S. brands — but only when the right foundations are in place before the first conversation.

Many early-stage brands approach OEM/ODM partners too quickly, without clear direction or regulatory awareness. This often leads to delays, misaligned expectations, or avoidable reformulation costs.

To help you prepare effectively, here are the key areas every U.S. buyer should clarify before engaging a Korean OEM/ODM partner.

1. Understand the Difference Between OEM and ODM

Before anything else, it is essential to understand how manufacturing models differ:

OEM (Original Equipment Manufacturer)You provide the formula, concept, and often the full product brief. The manufacturer produces it according to your specifications.

ODM (Original Design Manufacturer)The manufacturer develops the formula, texture, and often the product concept based on your direction.

In the Korean beauty industry, most manufacturers operate primarily under an ODM model, offering strong formulation libraries and in-house R&D capabilities.

This distinction is critical because it shapes how much control, speed, and customization you should expect.

2. Define Your Product Direction Clearly

One of the most common gaps in early discussions is lack of product clarity.

Before your first meeting, be prepared to define:

Product category (e.g., serum, toner, sunscreen, cream)
Target claims (hydration, anti-aging, brightening, barrier repair, etc.)
Texture and sensorial expectations
Price positioning (mass, masstige, premium)

“We want something like K-beauty skincare” is not enough for meaningful formulation discussions. The more specific your direction, the more efficiently manufacturers can support you.

3. Regulatory Pathway for the U.S. Market (Critical)

Not all cosmetics are treated equally in the U.S. market.

For example:

Sunscreens are regulated as OTC drugs, not cosmetic products.

This has major implications:

Manufacturing must follow OTC drug requirements
Facility registration and compliance standards are stricter
Documentation and testing requirements are significantly higher

In addition, under MoCRA (Modernization of Cosmetics Regulation Act), cosmetic manufacturers must also meet expanded compliance expectations in areas such as:

Safety substantiation
Facility registration
Adverse event reporting readiness

It is essential to confirm whether your Korean manufacturer is:

Registered for cosmetic compliance under MoCRA
Capable of OTC drug-level production (if applicable)

This step alone can determine whether your product can legally enter the U.S. market on schedule.

4. Minimum Order Quantity (MOQ) & Lead Time

Operational alignment is just as important as formulation.

Key considerations include:

MOQ requirements vary significantly depending on formula complexity and packaging type
Lead times typically range from 3 to 6+ months, sometimes longer for custom development
Packaging sourcing can be a separate bottleneck

Aligning expectations early prevents cost overruns and production delays later in the process.

5. Documentation & Testing Capabilities

U.S. market entry requires more than just a finished product. You should confirm whether your manufacturer can support:

Stability testing
Microbial and safety testing
Regulatory documentation suitable for U.S. compliance
Ingredient and formulation transparency

These elements are often overlooked but are essential for retail readiness and regulatory review.

Conclusion

One of the biggest mistakes U.S. brands make is assuming all manufacturers operate under the same standards and expectations.

They do not.

Preparation is not just about being organized — it is about positioning your brand as a credible, market-ready partner from the very first conversation.A well-prepared buyer does not just source products. They build strategic manufacturing partnerships.